Reinnervate and Kirkstall to Collaborate on New 3D Cell Culture Products
News Mar 19, 2012
“We are delighted that Kirkstall have decided to offer Alvetex scaffold at the heart of their 3D Quasi-Vivo platform” commented Richard Rowling, Commercial Director at Reinnervate. “Alvetex scaffold is becoming the industry standard for scientists who need to retain the native structure and functionality of cells to better mimic in-vivo biological models” he added.
The two companies aim to launch the new joint product at the Kirkstall-sponsored 'Advances in in-vitro cell culture’ meeting in Utrecht on 22-23 May 2012.
Malcolm Wilkinson, CEO of Kirkstall Ltd said, “life scientists are beginning to realise that perfusion based cell culture systems can significantly improve the biological relevance of in- vitro cell based assays. The Quasi-Vivo system already helps many leading laboratories improve the predictive accuracy of their ADMET studies. The early data we have that combines perfusion based cell culture with 3D cell growth shows stunning differences when compared to traditional 2D approaches.”
New Class of Decoy Molecules that Prevent the Onset of PainNews
Researcher report a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain.READ MORE
Targeted Cancer Treatment Could be Possible Thanks to Insights into Cells’ Energy SupplyNews
Researchers have shown that the enzyme EXD2 is critically involved in maintaining efficient protein production in mitochondria - the compartment responsible for making the energy required for cells to survive and replicate.
It is hoped the discovery could be used to target tumours in cancer patients in a new way while also significantly adding to the understanding of the vital role mitochondria plays in the functioning of a healthy cell.